By deciphering the molecular events associated with PAR1 activation, we pursue to uncover potential regulatory networks that influence the responses of MPN cells to PAR1 inhibition by detection of changes in PAR pathway related genes. The gene discussed is F2R; the disease is myeloproliferative disorder.